Please login to the form below

Not currently logged in
Email:
Password:

Bina Rawal joins ABPI as medical, innovation and research director

Appointment comes as trade body prepares for drug pricing discussions

Bina Rawal ABPIThe Association of the British Pharmaceutical Industry (ABPI) has appointed the Wellcome Trusts' Dr Bina Rawal as medical, innovation and research director.

Dr Rawal will join the ABPI in October, 2012, at what will be a crucial time for the UK's pharma industry as it approaches discussions about the future shape of the country's drug pricing system.

She will be central to this process, serving as senior medical spokesperson for the industry trade body when dealing with government, the media and professional organisations, as well as holding responsibility for advancing the productivity of the innovation process in the UK.

“We need a strong voice for innovation in the industry and Bina's experience and background will complement that of our members' to champion science, discovery, research and development and enable it to thrive in the UK," said the ABPI's chief executive Stephen Whitehead.

During her three years at the Wellcome Trust, Dr Rawal served as head of clinical development within the research charity's technology transfer division.

In this role, she was responsible for oversight and governance of the division's clinical pipeline, derived from the funding of translational research, clinical validation work and the development of new products, including medicines and devices.

Prior to her time at the Wellcome Trust, she spent several years at Roche, including serving as therapeutic area expert in the UK, and Dr Rawal gained further big pharma experience at GlaxoWellcome, where she worked in its R&D division.

“The pharmaceutical industry plays a vital role as a healthcare provider in the UK and research and development are an integral part of the patient journey through the NHS,” said Dr Rawal.

“I am very excited about working with members, the innovation board and many stakeholders to demonstrate and enhance this contribution for the benefit of patients and the UK economy."

31st July 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics